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The prevalence of peripheral arterial occlusive dis-
ease (PAOD) increases with aging, and it has been
estimated that the biennial incidence rate of inter-
mittent claudication is 26.6 per 1000 men and 13.3
per 1000 women.1 The risk factors for PAOD
include male sex, hypertension, hyperlipidemia, dia-
betes mellitus, cigarette smoking, and elevated
homocysteine levels.2,3 Exercise rehabilitation plays
an important role in improving the functional per-
formance of patients with PAOD, manifested by
increases in distances to onset and to maximal claudi-
cation pain and improvement in walking economy
(ie, efficiency).4,5 Exercise rehabilitation may also
have beneficial effects on risk factors that contribute
to the development of this disease. Although exten-
sive evidence exists demonstrating that exercise
improves hypertension, glucose intolerance, and
hyperlipidemia in patients without PAOD,6-10 it
remains unclear whether exercise rehabilitation has
an impact on cardiovascular risk factors in patients
with PAOD.11,12 Although large functional gains
occur in patients with claudication after exercise
rehabilitation, it is possible that the absolute amount
of exercise in this debilitated population is insuffi-
cient to elicit favorable alterations in cardiovascular
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risk factors. The objective of this study was to deter-
mine whether an exercise rehabilitation program
designed specifically to improve the ambulatory




The Institutional Review Board for human studies
at the University of Maryland in Baltimore approved
all procedures in this study. All patients provided
informed consent before participation. Community-
dwelling patients with symptomatic PAOD were
recruited from the Baltimore–Washington, DC, met-
ropolitan area for the participation in this research
study. Subjects were recruited from the vascular clinic
at the Baltimore location of the Maryland Veterans
Affairs Health Care System, from newspaper and radio
advertisements, and from senior citizen centers. All
patients had stage II PAOD as defined by Fontaine13
and the following inclusion criteria: a positive result
from a Rose questionnaire for intermittent claudica-
tion,14 intermittent claudication during a screening
treadmill test, an ankle/brachial index (ABI) at rest of
less than 0.97,15 and a drop of ABI under 0.85 during
exercise. The subjects were excluded if any of the fol-
lowing were present: absence of PAOD; asymptomatic
PAOD (Fontaine stage I); rest pain (Fontaine stage
III) or tissue loss (Fontaine stage IV); exercise toler-
ance limitations other than claudication (ie, severe
coronary artery disease [CAD], dyspnea, poorly con-
trolled blood pressure); severe arthritis that limited
exercise; and active cancer, renal disease, or liver dis-
ease. In this paper we report the results of 34 patients
(mean age, 68 ± 8 years; range, 54–84 years) who
completed 6 months of exercise rehabilitation pro-
gram (exercise group). We also report the results of 14
nonexercising patients with stage II PAOD, of compa-
rable age and medical comorbidities, who were
enrolled in longitudinal studies and evaluated after 6
months of follow-up and who served as methodologi-
cal controls (nonrandomized control group). All the
subjects in the longitudinal control group were former
smokers. Thirty-one of the patients (91%) in the exer-
cise group were male, and 12 patients (35%) were
African American. Thirteen (93%) of the patients in
the control group were male, and 5 patients (36%)
were African American. The major medical comor-
bidities of the exercise and control groups are de-
scribed in Table I.
Measurements
The following measurements were obtained
before patients entered the exercise rehabilitation
program and after the 6-month intervention.
Maximal treadmill test. Patients performed a
progressively graded treadmill test16 (2 mph speed
starting at 0% grade and increasing 2% grade every 2
minutes) that came to an end when maximal claudi-
cation pain was reached. The primary outcomes
determined by the treadmill test were the times to
onset and maximal claudication and peak oxygen
uptake (VO2). Patients used a claudication pain scale
to identify their degree of leg pain during the exer-
cise test, and the time to onset and to maximal pain
was recorded. The peak VO2 was obtained by indi-
rect calorimetry, as gas exchange measurements
were obtained every 20 seconds during exercise
using a metabolic measurement cart (Model 2900;
Table I. Comorbities of subjects in the study
Exercise intervention group (n = 34) Control group (n = 14)
Coronary artery disease 14 (41%) 6 (43%)
Coronary artery bypass graft 5 (16%) 2 (14%)
Hypertension 26 (77%) 11 (79%)
Diabetes 11 (32%) 7 (50%)
Dyslipidemia 28 (82%) 10 (71%)
Obesity 15 (44%) 4 (29%)
Cancer 7 (21%) 2 (14%)
Smoker 33 (97%) 14 (100%)
Current smoker 26 (77%) 0 (0%)
Former smoker 7 (21%) 14 (100%)
Cerebrovascular disease 6 (18%) 1 (7%)
Carotid endarterectomy 2 (6%) 0 (0%)
Transitory ischemic accident 3 (9%) 1 (7%)
Chronic obstructive pulmonary disease 9 (27%) 1 (7%)
Arthritis 11 (32%) 2 (14%)
Depression 7 (21%) 4 (28%)
JOURNAL OF VASCULAR SURGERY
672 Izquierdo-Porrera et al April 2000
Sensormedics, Inc, Anaheim, Calif). Peak oxygen
uptake was determined by averaging the two highest
20-second oxygen uptake values.
Blood pressure measurements. Brachial blood
pressure (BP) was obtained by oscillometry after the
patient had been lying supine for 10 minutes. The
oscillometric-derived brachial BP was obtained with
an automated Dinamap Vital Signs Monitor (Model
1846-SX; Critikon, Inc, Tampa, Fla). We previously
reported that the accuracy of determining brachial
systolic BP and ABI in patients with PAOD with
intermittent claudication was nearly identical to the
measures obtained with the Doppler ultrasound
technique.17
Ankle/brachial systolic pressure index. After
the subject had been lying supine for 10 minutes,
ankle systolic pressure was measured with a nondi-
rectional Doppler flow detector (Model 810-A;
Parks Medical Electronics, Inc, Aloha, Ore), a pen-
cil probe (9.3 MHz), and a standard-sized ankle BP
cuff (10-cm width). Measurements were taken from
the posterior tibial and dorsalis pedis arteries in both
legs. The higher of the two pressures in the more
severely diseased leg was recorded as the resting
ankle systolic pressure. The ABI was obtained by
dividing the ankle systolic pressure by the brachial
systolic pressure of the arm that had the higher sys-
tolic BP.
Lipids and glucose. A fasting blood sample was
drawn into chilled EDTA on two different occasions
to determine the concentration of cholesterol, triglyc-
erides, low-density lipoprotein cholesterol (LDL-C),
and high-density lipoprotein cholesterol (HDL-C);
the results were averaged. Plasma triglycerides and
cholesterol were measured enzymatically on a Hitachi
717 Autoanalyzer (Hitachi, Tokyo, Japan).18,19
Plasma HDL-C was measured in the supernatant after
precipitation of the apolipoprotein B–containing
lipoproteins with dextran sulfate.20 The LDL-C was
calculated using the Friedewald equation.21 The fast-
ing glucose was also determined as part of an auto-
mated battery of tests.
Study protocol
The exercise program consisted of three sessions
per week during 6 months of supervised, intermittent
treadmill walking to near maximal claudication pain.
Both the duration and intensity of sessions were pro-
gressively increased during the program. The program
was designed according to our recommendations from
a published meta-analysis.22 For the first month, sub-
Fig 1. Relationship between the baseline levels of choles-
terol and its change after the exercise rehabilitation.
Fig 2. Relationship between the baseline levels of LDL-
C and its change after the exercise rehabilitation. LDL-C,
Low-density lipoprotein cholesterol.
Fig 3. Relationship between the baseline systolic BP and its
change after the exercise rehabilitation. BP, Blood pressure.
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jects walked for 15 minutes; thereafter there was an
increase of 5 minutes per month, up to 40 minutes of
walking. Walking intensity was set between 50% and
80% of the maximal workload and was individually
adjusted throughout the program. Patients walked at
2 mph until their pain reached a level 3 on a 0 to 4
pain scale (0 = no pain, 1 = onset of pain, 2 = moder-
ate pain, 3 = intense pain, and 4 = maximal pain), after
which they rested. This intermittent pattern of walking
and resting continued until the target number of min-
utes of walking was accomplished. Five minutes of
cycling on a stationary bicycle were used as warm-up
and cooldown in each session. Antihypertensive,
antianginal, and diabetes medications had been adjust-
ed before patients entered the study, as needed to meet
the safety criteria established by the American College
of Sports Medicine for exercise testing and training.23
During the exercise rehabilitation intervention, med-
ications were stable, no major changes were intro-
duced into the medication profile, and the doses of the
drugs were not changed. This was assessed using a
direct interview of the patient and/or the computer-
ized pharmacy system. Compliance with the medica-
tion regime during the exercise rehabilitation program
was not formally assessed.
Dyslipidemia was defined as an LDL-C higher
than 160 mg/dL, an HDL-C lower than 35 mg/dL,
a triglyceride higher than 250 mg/dL, and/or the
use of lipid-lowering medications that followed the
National Cholesterol Education Program (NCEP)
guidelines.24 Because these patients had overt periph-
eral atherosclerosis, we used 100 mg/dL to define the
desirable LDL-C level.24 Hypertension was defined as
a systolic BP higher than 140 mm Hg and/or a dia-
stolic BP higher than 90 mm Hg on two or more vis-
its and/or with the use of BP medications. According
to the Expert Committee on the Diagnosis and
Classification of Diabetes Mellitus criteria,25 impaired
glucose tolerance was defined as a fasting glucose
between 110 and 126 mg/dL, and diabetes was
defined as a fasting glucose higher than 126 mg/dL
and/or the use of hypoglycemic agents. Obesity was
defined as a body mass index (BMI) higher than 27
kg/m2.
Statistical methods
Descriptive statistics were performed for each of
the physical function and cardiovascular risk factor
measures at baseline and 6 months. Data are reported
as mean ± SE with patients consuming their prescribed
medications. The change in physical function and car-
diovascular risk factors was computed as the difference
between the measure at 6 months and the measure at
baseline. Student t tests were performed to determine
if the mean change within the group after exercise
rehabilitation was statistically significant. A two by two
analysis of variance (ANOVA) with group x interven-
tion was used to compare the change in parameters in
the exercise and control groups. Because the change in
peak walking time was not normally distributed, a
Wilcoxon signed rank test was used to determine
whether the baseline was significantly different from
the 6-month peak walking time. An analysis of covari-
ance was performed adjusting for the initial baseline
value to determine if the exercise response depended
on the value of each measure at baseline. An F test was
used to determine if the baseline value significantly
affected the change in response. All statistical tests
were performed at the 0.05 level of significance.
RESULTS
Functional performance. At baseline, the
functional performance measures, ABI, and cardiac
risk factors were similar between the exercise and
control groups (Tables II and III). The effects of the
exercise rehabilitation intervention on the function-
Table II. Effects of the intervention on ABI and functional performance parameters
Exercise intervention group (n = 34) Control group (n = 14)
Baseline 6 mo Baseline 6 mo
ABI 0.61 ± 0.03 0.63 ± 0.03* 0.66 ± 0.03 0.67 ± 0.03
Time to onset of pain (min:sec) 3:14 ± 0:31 6:40 ± 0:59†‡ 2:44 ± 0:24 3:49 ± 0:54
Time to maximal pain (min:sec) 7:37 ± 0:49 12:31 ± 1:05†‡ 6:52 ± 0:56 7:36 ± 1:08
Peak VO2 (mL/kg/min) 13.6 ± 0.7 14.5 ± 0.7* 14.2 ± 0.8 13.7 ± 0.7
Results are expressed as mean ± SE.
*Intragroup analysis P <.05
†Intragroup analysis P <.01.
‡Intergroup analysis P <.05.
ABI, Ankle/brachial index; VO2, oxygen uptake.
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al performance measurements are summarized in
Table II. The times to onset and maximal claudica-
tion pain improved significantly by 106% (P <.0001)
and 64% (P <.0001), respectively. The peak VO2
increased significantly by 7% after the exercise inter-
vention (P <.05). The ABI also increased by 3.3%
after the intervention (P <.01). By contrast, there
were no significant changes in the functional perfor-
mance measures or ABI in the control group (Table
II). The changes in claudication pain times with
exercise rehabilitation were significant when com-
pared with the control group (ANOVA).
Cardiovascular risk factors. Lipid values,
BMI, BPs, and fasting glucose at baseline and after
exercise rehabilitation are described in Table III.
With intervention, total cholesterol and LDL-C sig-
nificantly decreased by 5% (P <.005) and 8% (P
<.01), respectively, (within group paired t test).
There also was a significant decrease in systolic BP of
6% (P <.05) with no change in diastolic BP. By con-
trast, there were no significant changes in the cardiac
risk factors in the control group (within group
paired t test, Table III). Although the two groups
displayed different patterns of change in cardiac risk
factors, the change in the exercise group was not
significantly different than the change in the con-
trols (ANOVA). The BMI, fasting glucose levels,
HDL-C, and triglycerides did not improve signifi-
cantly after the intervention (Table III). Ten patients
who were current smokers reduced their consump-
tion by 55%, whereas the remaining 15 current
smokers had no change. These data are reported
elsewhere.26 There were no significant correlations
between the changes in functional performance and
the changes in cardiovascular risk factors.
Relationship between baseline values and
changes in cardiovascular risk factors. We exam-
ined the relationship between the initial values of the
cardiovascular risk factors and the changes in cardio-
vascular risk factors values after the intervention. In
regressions analysis, the initial value accounted for
22% (r = –0.47; P <.01) of the effect of the exercise
rehabilitation program on cholesterol (Fig 1) and
20% on LDL-C (r = –0.45, P <.01) (Fig 2). Patients
with higher initial values had greater improvements
after the intervention than patients with lower (nor-
mal) initial values. The change in systolic BP with
exercise rehabilitation was also inversely related to
the baseline value (r = –0.60, P <.01) (Fig 3),
because patients with the highest initial values
demonstrated the greatest improvements.
Adequacy of treatment in patients with abnor-
mal values of cardiovascular risk factors. At base-
line, 16 (55%) of 29 patients in the exercise group
with elevated LDL-C levels (>100 mg/dL), and 8
(73%) of 11 patients with low values of HDL-C were
untreated. None of the 13 patients on lipid-lowering
medications had LDL-C levels below 100 mg/dL.
Despite the overall reductions in cholesterol and
LDL-C concentrations, at the end of the interven-
tion there were only modest improvements in the
number of patients who met the desirable LDL-C
values for patients with cardiovascular disease as
defined by the NCEP guidelines. Only 6 (21%) of 29
patients who had LDL-C levels of more than 100
mg/dL at baseline, fulfilled the NCEP guidelines for
LDL-C after exercise rehabilitation.
At baseline 21 (81%) of the 26 patients with
hypertension were taking medications. Only 11
(52%) of the 21 patients taking antihypertensive
medications were well controlled (systolic BP <140
mm Hg and diastolic BP <90 mm Hg). After exer-
Table III. Effects of the intervention on cardiovascular risk factors
Exercise intervention group (n = 34) Control group (n = 14)
BMI 27.7 ± 0.9 27.8 ± 0.9 30.1 ± 1.3 30.1 ± 1.3
SBP 139 ± 4 131 ± 3* 138 ± 4 137 ± 5
DBP 72 ± 2 70 ± 2 71 ± 2 69 ± 2
Fasting glucose 123 ± 7 120 ± 7 123 ± 9 128 ± 15
Cholesterol 193 ± 4 183 ± 4† 204 ± 13 193 ± 10
Triglycerides 156 ± 11 153 ± 11 158 ± 14 150 ± 18
HDL-C 39 ± 2 39 ± 2 38 ± 3 37 ± 3
LDL-C 123 ± 4 113 ± 4† 124 ± 7 120 ± 6
Results are expressed as mean ± SE.
*Intragroup analysis P <.05
†Intragroup analysis P <.01.
BMI, Body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein
cholesterol; SBP, systolic blood pressure.
cise rehabilitation, 8 of the 21 patients taking med-
ication had a systolic BP of more than 140 mm Hg.
Regarding the adequacy of the treatment of dia-
betes, at baseline only 7 of the 11 patients with dia-
betes were taking medications (six patients with tak-
ing oral agents, one was taking insulin). Only one of
the seven treated patients, and none of the four
untreated patients had fasting glucose levels below
126 mg/dL. Therefore, 10 of the 11 patients with
diabetes had fasting glucose levels of more than 126
mg/dL. After exercise rehabilitation six of the seven
medicated patients and two of the four unmedicated
patients with diabetes still had fasting glucose levels
above 126 mg/dL.
DISCUSSION
Cardiovascular risk factor modification is an
important element of the treatment of PAOD. In our
study the exercise rehabilitation program lowered
LDL-C levels by 8% and total cholesterol levels by 5%.
Exercise rehabilitation also reduced systolic BP, the
most prevalent cardiovascular risk factor in our
patients, by 6%. These beneficial changes in the car-
diac risk factor profiles may potentially reduce the rate
of progression of atherosclerosis, as well as the associ-
ated complications. Therefore, exercise rehabilitation
is an integral part of the management of patients with
PAOD.
Functional performance. The times to onset
and maximal claudication pain improved 106% and
64% after exercise rehabilitation, respectively. These
findings are consistent with previous studies.11,27-31
Although these changes are important, it must be
pointed out that at the end of the intervention peri-
od the patients still had important impairment due
to claudication. With respect to the change in ABI,
although the 3% improvement in the exercise group
is statistically significant, it has little clinical signifi-
cance. The fact that we found no significant correla-
tion between changes in functional performance and
changes in cardiovascular risk factors suggests that
exercise acts through different mechanisms to
achieve improvements in these parameters. In our
population the increase of VO2 was significant but
moderate, probably because of the low absolute
exercise training intensity.
Cardiovascular risk factors. A large number of
studies have examined the effects of exercise training
on the lipid profile, BP, and fasting glucose levels in
healthy individuals. Although beneficial effects have
been shown, the magnitude of these changes in car-
diac risk factors varies among studies.9,32,33 We are
only aware of two studies that have examined the
changes of lipid profile after an exercise rehabilita-
tion program in patients with PAOD. In a study by
Feinberg et al,12 there were no significant changes in
lipids after a 12-week exercise rehabilitation pro-
gram in patients with PAOD. On the other hand,
Williams et al13 reported a decrease of triglycerides
of 31% at the end of their 12-week exercise rehabil-
itation program. In the same study an 18% change in
cholesterol was detected a year into the maintenance
phase, but not after the 12-week period, whereas in
our study the lipid changes where detected at 6
months. This suggests that the results of the PAOD
studies may differ because of the various lengths of
the exercise rehabilitation programs.
Given the extensive arteriosclerosis of patients
with CAD, an examination of the effects of cardiac
rehabilitation on CAD risk factors in patients with
CAD is a useful model for comparison with PAOD.
Changes in the lipid profiles of patients with CAD
after a rehabilitation program have been described
by various authors to range from a 1% to 5% decrease
of total cholesterol, a 6% to 16% decrease of triglyc-
erides, a 6% to 10% increase in high-density lipopro-
tein, and a 3% to 13% decrease of low-density
lipoprotein.34-38 The lack of change in HDL-C in
the present study may have been due to the low vol-
ume of exercise that could be accomplished by our
functionally limited patients. It has been shown that
exercise-induced changes in HDL-C depend, in
part, on the absolute amount of exercise, age, length
of training, initial levels of cardiovascular risk factors,
VO2max, body weight, and percentage of body
fat.33,39-41 Although our patients trained at a rela-
tively high intensity (70%-80% of their peak VO2)
their absolute intensity was low (3-4 metabolic
equivalents of oxygen consumption).
Blood pressure has been shown to improve after
an exercise program in healthy individuals.10,42 We
are not aware of any studies that specifically address
the changes in BP after an exercise rehabilitation
intervention in patients with PAOD. In our older
PAOD population, we found an improvement of 6%
in systolic BP, which is consistent with the changes
that have been described for healthy populations.
The relationship between the change in BP and the
intensity of exercise remains controversial because
improvements in systolic and diastolic BP have been
described when people exercised as low as 40% of
their predicted maximal heart rate.42-44
In our population the changes in cholesterol,
LDL-C, and BP after an exercise intervention were
a function of the initial value. Individuals with more
abnormal initial values tend to change more with the
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intervention. We had previously shown this in obese
postmenopausal women where the changes in lipid
profile after a weight-loss diet were a function of the
initial value.45 Nevertheless, it must be acknowl-
edged that these changes could in part be due to
regression to the mean.
We studied major cardiovascular risk factors that
should be routinely evaluated and aggressively treated
in patients with cardiovascular disease. McDermott et
al46 described that atherosclerotic risk factors were
less intensively treated in patients with PAOD than in
patients with CAD. This is consistent with our study
where up to 73% of patients with abnormal values of
cardiovascular risk factors were not treated at baseline.
Although the intervention improved some of these
risk factors, a substantial number of patients still did
not meet established criteria after the 6-month exer-
cise program, particularly for hyperlipidemia.
Strengths and limitations. One of the strengths
of this paper is that we recruited and trained a well-
characterized PAOD population with a well-described
stage of disease. All the patients underwent a compre-
hensive medical evaluation. The fact that the training
prescription was intermittent and used low absolute
intensities may allow its beneficial outcomes to be
reproduced in community settings where patients do
not exercise under strict supervision. The major study
limitation is the lack of a randomized control group. It
is possible that some of the beneficial changes we
observed were due in part to regression to the mean.
We believe that this is unlikely given the lack of change
in the nonrandomized control group. A second limita-
tion is that while the intragroup change in cardiac risk
factors was significant in the exercise group (paired t
test), the change in risk factors in the exercise group
was not significant when compared with the control
group (ANOVA). The finding of a significant result
within a group but not between groups may be due to
the modest sample size. Post hoc power calculations
suggest that a sample size of more than 100 would be
required to show a significant difference for the
between-group effects. These control group limitations
are currently being addressed in an ongoing random-
ized control trial that examines the effects of exercise
rehabilitation on function in patients with PAOD.
Another potential limitation of this study is that,
although there were no substantial changes in the pre-
scribed medications over the course of this study,
changes in compliance could account for some of the
improvement in the cardiovascular risk profiles. Also,
although we selected clinically relevant cardiovascular
risk factors, we did not assess other factors (eg,
increased homocysteine levels) that have been
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described to increase the risk for PAOD. Finally, we
used a select population of predominantly male patients
with Fontaine stage II PAOD. Our results may not be
applicable to female patients with PAOD, and the
results might not be generalizable to other populations
of patients with PAOD. In conclusion, exercise rehabil-
itation not only improves functional performance, but
also results in favorable alterations in cardiovascular risk
factor profile, which are important elements of the
treatment of PAOD.
Appreciation is extended to Polly S. Montgomery,
MS, for patient recruitment and screening, and to Lynda
Cowell, MS, and Tresa Almy-Albert, MS, for testing and
rehabilitating the patients.
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